CEL-SCI Corporation news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

CVM 1.96 +0.07 (3.70%)
price chart
CEL-SCI Announces Robert Watson Joins Its Board of Directors
“I am excited to join CEL-SCI's board at this time, as the Company approaches evaluating the endpoint of its Phase 3 results, which may lead to a new and much needed immunotherapy to treat head and neck cancer.
CEL-SCI Reports Fiscal 2017 Financial Results and Clinical & Corporate ...
CEL-SCI's LEAPS vaccine for the treatment of rheumatoid arthritis received a $1.5 million grant from the U.S. National Institutes of Health (NIH).
$0.52 EPS Expected for BofI Holding, Inc. (BOFI); Cel Sci (NYSEAMERICAN:CVM ...  Wolcott Daily
CEL-SCI Reaches Full Enrollment in Pivotal Phase 3 Head and Neck Cancer Study
Factors that could cause or contribute to such differences include, an inability to duplicate the clinical results demonstrated in clinical studies, timely development of any potential products that can be shown to be safe and effective, receiving ...
CEL-SCI (CVM) Scheduled to Post Quarterly Earnings on Tuesday  The Lincolnian Online
CEL-SCI Reports Recent Data Review By the Independent Data Monitoring ...
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) announced today that the Independent Data Monitoring Committee (IDMC) for the Company's pivotal Phase 3 head and neck cancer study of its investigational immunotherapy Multikine ...
CEL-SCI Corp (CVM) Reports Data Review By IDMC for Its Pivotal Phase 3 Head ...  StreetInsider.com
What Next for Cel Sci Corporation (NYSEAMERICAN:CVM) Stock After Decrease in ...
The stock of Cel Sci Corporation (NYSEAMERICAN:CVM) registered a decrease of 11.83% in short interest. CVM's total short interest was 462,000 shares in December as published by FINRA.
Critical Media Coverage Very Likely to Impact CEL-SCI (CVM) Stock Price  BangaloreWeekly
CEL-SCI Corporation (CVM) Recent Ownership Changes
CEL-SCI Corporation (NYSE:CVM) has made a 34.76% comeback from a 12-month low price of $1.46. It was seen 6.92% higher, changing the price to $1.97, when the closing bell rang on 12/18/2017.
Analyst's Hold rated Stock: CEL-SCI Corporation (CVM)
CEL-SCI Corporation (CVM) stock price traded with surging change along with the volume 0.06 million shares in Friday trading session.
Analyst Research Roundup: Sucampo Pharmaceuticals, Inc. (SCMP), CEL-SCI ...
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) tinted gains of +2.56% (+0.4 points) to US$16. The volume of 3.43 Million shares climbed down over an trading activity of 896.09 Million shares.
2 Stocks To Invest: CEL-SCI Corporation (CVM), the Rubicon Project, Inc. (RUBI)
CEL-SCI Corporation (NYSE:CVM) shares ended at $1.86 with 0.07 mln shares exchanging hands. That puts the market capitalization at $20.87 mln.
Here's Why These Two Are Trending: JAKKS Pacific, Inc. (JAKK), CEL-SCI ...
JAKKS Pacific, Inc. (NASDAQ:JAKK) shares ended at $2.65 with 0.12 mln shares exchanging hands. That puts the market capitalization at $74.2 mln.